Drug intelligence / Profile preview

norepinephrine + L-NAME + ascorbic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Intravenous, Intraperitoneal
01

Overview

This is a combination of three agents: - **Norepinephrine** is a catecholamine neurotransmitter and hormone that acts primarily on alpha- and beta-adrenergic receptors, leading to vasoconstriction and increased blood pressure. It is used clinically as a sympathomimetic agent for the management of acute hypotensive states such as septic shock[4][5]. - **L-NAME (N^G^-Nitro-L-arginine methyl ester)** is an inhibitor of nitric oxide synthase (NOS), thereby reducing the production of nitric oxide, which leads to vasoconstriction by preventing vascular smooth muscle relaxation. - **Ascorbic acid (Vitamin C)** serves as an antioxidant and enzymatic cofactor. In this context, it enhances norepinephrine synthesis by acting as a cofactor for dopamine β-hydroxylase, the enzyme that converts dopamine to norepinephrine[1][2]. Ascorbic acid also protects cells from oxidative stress during catecholamine synthesis. This combination may be used in experimental or research settings to study vascular tone regulation, catecholamine biosynthesis, or oxidative stress responses. There are no known approved pharmaceutical products containing all three components together; their use in combination would be investigational.

02

Targets

DBH (Dopamine beta-hydroxylase)NOS1 (nNOS)ADRB1 (β1)ADRA1A (α1A)

Beyond the preview

Go deeper on norepinephrine + L-NAME + ascorbic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on norepinephrine + L-NAME + ascorbic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call